» Articles » PMID: 20606445

Ranking the Harm of Alcohol, Tobacco and Illicit Drugs for the Individual and the Population

Overview
Journal Eur Addict Res
Publisher Karger
Specialty Psychiatry
Date 2010 Jul 8
PMID 20606445
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Drug policy makers continuously face a changing pattern of drug use, i.e. new drugs appear on the market, the popularity of certain drugs changes or drugs are used in another way or another combination. For legislative purposes, drugs have mostly been classified according to their addictive potency. Such classifications, however, lack a scientific basis. The present study describes the results of a risk assessment study where 19 recreational drugs (17 illicit drugs plus alcohol and tobacco) used in the Netherlands have been ranked by a Dutch expert panel according to their harm based on the scientific state of the art. The study applies a similar approach as recently applied by Nutt et al. [Lancet 2007;369:1047-1053], so that the results of both studies could be compared. The harm indicators scored are acute and chronic toxicity, addictive potency and social harm. The aim of this study is to evaluate whether the legal classification of drugs in the Netherlands corresponds with the ranking of the drugs according to their science-based ranking of harm. Based on the results, recommendations are formulated about the legal classification of recreational drugs at national and international level which serves a rational approach for drug control.

Citing Articles

A critical assessment of the abuse, dependence and associated safety risks of naturally occurring and synthetic cannabinoids.

Heal D, Gosden J, Smith S Front Psychiatry. 2024; 15:1322434.

PMID: 38915848 PMC: 11194422. DOI: 10.3389/fpsyt.2024.1322434.


Examining the Gateway Hypothesis and Mapping Substance Use Pathways on Social Media: Machine Learning Approach.

Yuan Y, Kasson E, Taylor J, Cavazos-Rehg P, De Choudhury M, Aledavood T JMIR Form Res. 2024; 8:e54433.

PMID: 38713904 PMC: 11109860. DOI: 10.2196/54433.


Psilocybin-assisted therapy for severe alcohol use disorder: protocol for a double-blind, randomized, placebo-controlled, 7-month parallel-group phase II superiority trial.

Vanderijst L, Hever F, Buot A, Daure C, Benoit J, Hanak C BMC Psychiatry. 2024; 24(1):77.

PMID: 38279085 PMC: 10821548. DOI: 10.1186/s12888-024-05502-y.


Consciousness alterations in a cohort of young Swiss men: Associations with substance use and personality traits.

Deligianni M, Studer J, Gmel G, Khazaal Y, Bertholet N Front Psychiatry. 2023; 13:1056159.

PMID: 36683973 PMC: 9846235. DOI: 10.3389/fpsyt.2022.1056159.


Differences between users' and addiction medicine experts' harm and benefit assessments of licit and illicit psychoactive drugs: Input for psychoeducation and legalization/restriction debates.

Bonnet U, Specka M, Kanti A, Scherbaum N Front Psychiatry. 2022; 13:1041762.

PMID: 36465301 PMC: 9709475. DOI: 10.3389/fpsyt.2022.1041762.